Ray Dalio's PTCT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 11,938 shares of PTC Therapeutics, Inc. (PTCT) worth $732,635, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in PTCT, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's PTC Therapeutics (PTCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly PTC Therapeutics (PTCT) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +11,938 | New Buy | 11,938 | $61.37 |
Ray Dalio's PTC Therapeutics Investment FAQs
Ray Dalio first purchased PTC Therapeutics, Inc. (PTCT) in Q3 2025, acquiring 11,938 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held PTC Therapeutics, Inc. (PTCT) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to PTC Therapeutics, Inc. (PTCT) was in Q3 2025, adding 11,938 shares worth $732,635. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 11,938 shares of PTC Therapeutics, Inc. (PTCT), valued at approximately $732,635. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, PTC Therapeutics, Inc. (PTCT) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in PTC Therapeutics, Inc. (PTCT) was 11,938 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.